Skip to main content
Figure 2 | BMC Biotechnology

Figure 2

From: Characterization of a modified ROCK2 protein that allows use of N6-ATP analogs for the identification of novel substrates

Figure 2

Creation of AS-ROCK2. A. ROCK2, V-Src, C-Src and rat PKA sequences were aligned using ClustalW. The v-Src ‘gatekeeper’ residue within the ATP-binding pocket is Ile338 (indicated by arrow) and is primarily responsible for restricting the ability of protein kinases from utilizing N6-substiuted ATP analogues. Ile338 in v-Src corresponds to Met160 in ROCK2. B. HEK 293 cells were transfected with various FLAG-ROCK2 constructs where indicated. The following day, cells were lysed and ROCK2 was immunoprecipitated with anti-FLAG conjugated agarose. LIMK peptide was phosphorylated using N6(Benzyl)ATP, loaded onto streptavidin plates (Pierce), and probed with P-LIMK (Cell Signaling) overnight at room temperature. Secondary decoration with IRDye® 680 anti-rabbit (Li-Cor) was performed at room temperature for 1.5 hours. LIMK peptide phosphorylation was visualized by direct fluorescence scanning with a Li-Cor Odyssey Imager. The relative LIMK phosphorylation signal is shown by the histogram for each ROCK2 mutation. Error bars represent standard deviation of triplicate determinations from three independent experiments. Asterisks indicate significant difference (P < 0.001) with W1161A ROCK2 as using Student’s t-test. C. Kinase activity of W1161A ROCK or W1161A/M160A ROCK2 was determined as in B, using serial dilutions of ATP with concentrations ranging from 1 mM to 12.8 nM. D. As in C, except N6(Benzyl)ATP was used. For C and D, error bars represent the range of duplicate determinations. Results are representative of three independent experiments.

Back to article page